Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

Abstract
Background: Patients affected by different types of autoimmune diseases, including common conditions such as Multiple Sclerosis (MS) and Rheumatoid Arthritis (RA), are often treated with immunosuppressants to suppress disease activity. It is not fully understood how the SARS-CoV-2 specific humoral and cellular immunity induced by infection and/or upon vaccination is affected by immunosuppressants.
Funding Information
  • ZonMw (#10430072010007)
  • European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (#860003)
  • European Commission (SUPPORT-E, #101015756)
  • European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (#792532)
  • NHMRC Leadership Investigator Grant (1173871)
  • PPOC (#20_21 L2506)